This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pincus, D. H.
Right arrow Articles by Hearn, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pincus, D. H.
Right arrow Articles by Hearn, V.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 1999, p. 3533-3539, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Rapid Identification of Candida dubliniensis with Commercial Yeast Identification Systems

D. H. Pincus,1,* D. C. Coleman,2 W. R. Pruitt,3 A. A. Padhye,3 I. F. Salkin,4 M. Geimer,1 A. Bassel,1 D. J. Sullivan,2 M. Clarke,2 and V. Hearn2

bioMérieux, Inc., Hazelwood, Missouri1; Department of Oral Medicine and Oral Pathology, School of Dental Science and Dublin Dental Hospital, Trinity College, University of Dublin, Dublin 2, Republic of Ireland2; Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia3; and Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany, New York4

Received 16 April 1999/Returned for modification 12 July 1999/Accepted 2 August 1999


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Candida dubliniensis is a newly described species that is closely related phylogenetically to Candida albicans and that is commonly associated with oral candidiasis in human immunodeficiency virus-positive patients. Several recent studies have attempted to elucidate phenotypic and genotypic characteristics of use in separating the two species. However, results obtained with simple phenotypic tests were too variable and tests that provided more definitive data were too complex for routine use in the clinical laboratory setting. The objective of this study was to determine if reproducible identification of C. dubliniensis could be obtained with commercial identification kits. The substrate reactivity profiles of 80 C. dubliniensis isolates were obtained by using the API 20C AUX, ID 32 C, RapID Yeast Plus, VITEK YBC, and VITEK 2 ID-YST systems. The percentages of C. dubliniensis isolates capable of assimilating or hydrolyzing each substrate were compared with the percentages from the C. albicans profiles in each kit's database, and the results were expressed as percent C. dubliniensis and percent C. albicans. Any substrate that showed >50% difference in reactivity was considered useful in differentiating the species. In addition, assimilation of methyl-alpha -D-glucoside (MDG), D-trehalose (TRE), and D-xylose (XYL) by the same isolates was investigated by the traditional procedure of Wickerham and Burton (L. J. Wickerham and K. A. Burton, J. Bacteriol. 56:363-371, 1948). At 48 h (the time recommended by the manufacturer for its new database), we found that the assimilation of four carbohydrates in the API 20C AUX system could be used to distinguish the species, i.e., glycerol (GLY; 88 and 14%), XYL (0 and 88%), MDG (0 and 85%), and TRE (15 and 97%). Similarly, results with the ID 32 C system at 48 h showed that XYL (0 and 98%), MDG (0 and 98%), lactate (LAT; 0 and 96%), and TRE (30 and 96%) could be used to separate the two species. Phosphatase (PHS; 9 and 76%) and alpha -D-glucosidase (23 and 94%) proved to be the most useful for separation of the species in the RapID Yeast Plus system. While at 24 h the profiles obtained with the VITEK YBC system showed that MDG (10 and 95%), XYL (0 and 95%), and GLY (26 and 80%) could be used to separate the two species, at 48 h only XYL (6 and 95%) could be used to separate the two species. The most useful substrates in the VITEK 2 ID-YST system were TRE (1 and 89%), MDG (1 and 99%), LAT (4 and 98%), and PHS (83 and 1%). While the latter kit was not yet commercially available at the time of the study, it would appear to be the most valuable for the identification of C. dubliniensis. Although assimilation of MDG, TRE, and XYL proved to be the most useful for species differentiation by the majority of commercial systems, the results with these carbohydrates by the Wickerham and Burton procedure were essentially the same for both species, albeit following protracted incubation. Thus, it is the rapidity of the assimilation achieved with the commercial systems that allows the differentiation of C. dubliniensis from C. albicans.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Candida dubliniensis, first described in 1995 by Sullivan et al. (27), has been isolated from various geographic locations (24, 25), most commonly from oral specimens from human immunodeficiency virus (HIV)-infected and AIDS patients (5, 24). C. dubliniensis has been implicated as an agent of oral candidiasis (5, 23) and can develop resistance to fluconazole (10, 16, 17, 19), a common antifungal drug used for the treatment of mycoses in AIDS patients. The yeast has also been recovered from vaginal, fecal, lung, sputum, and blood specimens from HIV-negative individuals (15, 16, 18, 20). While only recently described, one isolate (formerly misidentified as C. stellatoidea) dates back to 1957, and another (formerly misidentified as C. albicans) dates back to 1952 (15, 24, 27). Retrospective studies of two yeast stock collections showed that approximately 2% of isolates originally identified as C. albicans were actually C. dubliniensis (5, 18). A similar investigation of a collection of oral yeast isolates from HIV-infected individuals originally identified as C. albicans revealed that 16.5% were C. dubliniensis (5).

C. dubliniensis is closely related phylogenetically to C. albicans and the former species C. stellatoidea (5), now considered to be a synonym of C. albicans (1, 11). Consequently, phenotypically, C. dubliniensis and C. albicans have many similarities, including their microscopic morphology and ability to form germ tubes in serum. Since many laboratories use the germ tube test (28) as their sole method for the identification of C. albicans, isolates of C. dubliniensis have been overlooked and misidentified as the former species (5, 18). In addition, both species typically produce blastoconidia with pseudohyphae, true hyphae, and chlamydospores. Some investigators have noted more abundant production and different arrangements (pairs, triplets, or clusters) of chlamydospores with C. dubliniensis (8, 27), but this can be somewhat subjective for clear separation of the two species (10).

The appearance of colonies on a chromogenic medium (i.e., CHROMagar Candida) has been considered a useful tool for recognition of C. dubliniensis, which is reported to develop dark green colonies after incubation at 37°C for 48 h, in contrast to the light green, light blue-green, or blue-green colonies seen with C. albicans (4, 5). However, the characteristic dark green colony pigment of C. dubliniensis may be lost after subculture or storage at -70°C, with colonies exhibiting the light green appearance of C. albicans (22, 24). It appears that incubation conditions are also important since colonies of C. albicans can have the same appearance as C. dubliniensis when they are grown for an extended period on CHROMagar Candida medium (18, 22). Although this method seems to have a high degree of sensitivity, specificity was lacking in some studies, suggesting that it should be used only as a screening tool for primary isolation of yeasts from clinical specimens and allows presumptive identification of C. dubliniensis in mixed cultures since it is often present with C. albicans (24).

Growth at 42°C was initially considered to be a useful test for differentiation of C. dubliniensis (no growth) from C. albicans (growth) in the original description of this new species (27). However, strains of C. dubliniensis which exhibit either poor (4, 5, 23-25) or good growth (10, 20, 22) at 42°C have been reported. In other temperature tolerance studies, 120 isolates of C. dubliniensis showed no growth, while 98 of 99 C. albicans strains grew at 45°C (20). However, in subsequent investigations only 18 of 28 C. albicans strains grew at 45°C (10).

Other phenotypic methods for the more definitive separation of C. dubliniensis from C. albicans have been described in the literature. Bikandi et al. (2) described the development of an immunofluorescence test based on the antibody detection of differential antigen expression on C. dubliniensis blastospores and C. albicans germ tubes. Furthermore, an intracellular beta -glucosidase (beta GLU) test was reported to indicate clear delineation between isolates of C. albicans and a cluster of "atypical C. albicans" (i.e., C. dubliniensis) isolates (3). A later study showed that all strains of C. dubliniensis were negative, but 11 of 481 C. albicans strains also tested negative (18). Although these methods provide other potential screening tests, they seem inefficient for routine use in clinical laboratories.

Several reports of studies that have used molecular methods to characterize the genetic difference between C. dubliniensis and C. albicans and their phylogenetic relationship (7, 26, 27) have appeared. These have included hybridization with C. albicans-specific probe 27A or Ca3 and C. dubliniensis-specific probe Cd2 (3, 4, 9, 10, 13, 18, 22, 25, 27), multilocus enzyme electrophoresis (3), oligonucleotide fingerprinting (4), electrophoretic karyotype analysis (4, 8, 25, 27), random amplified polymorphic DNA analysis (4, 25, 27), restriction fragment length polymorphism analysis (10, 14, 25-27), and rRNA sequencing analysis (4, 25-27). Data from those studies support C. dubliniensis as a new taxon separate from C. albicans and its synonym C. stellatoidea. However, these methods are labor-intensive and expensive and require special equipment, making them unsuitable for most clinical laboratories.

While several studies with C. dubliniensis have included data from the substrate assimilation-based ID 32 C or API 20C AUX yeast identification systems (3, 4, 8, 10, 13, 21, 22, 25, 27), this new species was not included in their respective databases when the studies were performed (before 1998). Thus, the biopatterns resulted in inconclusive identifications (not corresponding to any taxa included in the databases) or misidentifications (usually as C. albicans or C. sake).

Simple phenotypic tests are useful screening tools but are too variable for definitive identification of C. dubliniensis. Genotypic tests (i.e., molecular typing methods) provide definitive data and clear-cut differentiation of species but are too complex for routine use in the clinical laboratory setting. The present study was undertaken to determine if C. dubliniensis could be identified reproducibly with commercial identification kits. We studied the profiles of 80 C. dubliniensis isolates obtained with the API 20C AUX, ID 32 C, RapID Yeast Plus, VITEK YBC, and VITEK 2 ID-YST systems. The data obtained in this study support the use of commonly used commercial systems for the rapid and precise recognition of C. dubliniensis in the clinical setting.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Test organisms. The 80 isolates of C. dubliniensis used in this study were from the culture collection of the Department of Oral Medicine and Oral Pathology, School of Dental Science and Dublin Dental Hospital, Trinity College, University of Dublin. All isolates were previously characterized by one or more of the molecular methods mentioned above. Cultures were maintained at -80°C in Protect cryovials (Technical Service Consultants Ltd., Lancashire, United Kingdom) or at -70°C in Trypticase soy broth with 15% (vol/vol) glycerol until the time of use. Frozen stocks were subcultured onto Sabouraud glucose agar (SGA; Oxoid, Poole, Dorset, United Kingdom, or Remel, Inc., Lenexa, Kans.) and were incubated at 30°C for 24 to 48 h before a second subculture to SGA. Colonies from the second subculture were used for testing. Incubation conditions (30°C for 18 to 48 h) for secondary SGA subcultures were as specified by the manufacturer for each of the respective commercial systems.

API 20C AUX system. The API 20C AUX system (bioMérieux, Marcy l'Etoile, France), a commercial kit for the evaluation of the assimilation of 19 carbon sources, was used according to the manufacturer's instructions. Since 48 to 72 h of incubation is recommended, test strips were incubated for both times to allow a comparative evaluation of the assimilation patterns. Numerical profiles were constructed from the reaction patterns and were used to obtain identification results with either the analytical profile index or the identification software program.

ID 32 C system. The ID 32 C system (bioMérieux) was used according to the manufacturer's instructions. The kit allows the evaluation of the assimilation of 29 carbon sources, growth in the presence of actidione (cycloheximide), and an esculin test (not used in the identification profile number). Test strips were incubated at 30°C for 48 h (24 to 48 h is recommended). Numerical profiles were constructed from the reaction patterns and were used to obtain identifications with the identification software program.

RapID Yeast Plus system. The RapID Yeast Plus system (Remel, Inc. [formerly Innovative Diagnostic Systems, Norcross, Ga.]) was used according to the manufacturer's instructions. This system permits investigation of the assimilation of five carbon sources and hydrolysis of 13 enzymatic substrates. The test panels were incubated at 30°C for 4 h. Numerical profiles were constructed from the reaction patterns and were used to obtain identifications with the code compendium.

VITEK YBC system. The VITEK YBC system (bioMérieux, Inc., Hazelwood, Mo.) was used according to the manufacturer's instructions. With this system, one may evaluate the assimilation of 23 carbon substrates, growth in the presence of cycloheximide, nitrate assimilation, and urea hydrolysis. Cards were read automatically at 24 h and again at 48 h for those that required additional incubation (flagged by the identification software). Numerical profiles were constructed automatically from the reaction patterns, and identifications were obtained with the instrument software.

VITEK 2 ID-YST system. The VITEK 2 ID-YST system (bioMérieux, Inc.) was used according to the manufacturer's instructions. This new system uses fluorogenic substrates to indicate the assimilation of 26 carbon substrates (adonitol, trehalose [TRE], N-acetyl-D-glucosamine, cellobiose, dulcitol, galactose, glucose, lactose, alpha -methyl-D-glucoside [MDG], maltose, mannitol, melibiose, melezitose, palatinose, raffinose, rhamnose, sucrose, salicin, sorbose, sorbitol, citrate, galacturonate, gluconate, lactate [LAT], mono-methyl ester succinate, and succinate), growth in the presence of actidione, nitrate assimilation, reactivity with 9 arylamidases (glycine, hydroxyproline, lysyl-alanine, gamma -glutamic acid, glycyl-glycine, histidine, isoleucine, proline, and valine), and reactivity with 10 other enzymes (alpha -galactosidase, alpha -glucosidase [alpha GLU], alpha -mannosidase, beta -galactosidase, beta GLU, beta -glucuronidase, N-acetyl-beta -glucosaminidase, beta -xylosidase, phosphatase [PHS], and urease). A yeast suspension was made in 0.45% (wt/vol) aqueous NaCl to achieve a turbidity equivalent to that of a no. 2 McFarland standard and was inoculated into the test card. The cards were incubated at 35°C for 15 h, and the test cards were read automatically at 15-min intervals. Biopatterns were constructed automatically, and reaction patterns were used to obtain identifications with the instrument software.

Wickerham and Burton procedure. The conventional broth tube method of Wickerham and Burton (29) was used to test assimilation of methyl-alpha -D-glucoside, D-trehalose, and D-xylose. A white card with 3-mm-wide ink lines was used to obtain turbidity measurements. Tubes were held against the card, and turbidity was considered 1+ if the lines were clear but indistinct, 2+ if the lines were diffused, and 3+ if the lines were obliterated. Assimilation and negative control tubes were inoculated with 100 µl of a dilute (1+ turbidity) yeast suspension in water, incubated at 30°C for 28 days, and read weekly for turbidity. Assimilation tubes were compared to negative control tubes for each isolate and were recorded as positive if 2+ or 3+ turbidity was observed. A 1+ turbidity reaction was considered very weak if the negative control tube was clear.

Nomenclature. The API 20C AUX and ID 32 C system databases list two biotypes of C. albicans (C. albicans 1 and C. albicans 2). C. albicans 1 represents the sucrose-positive isolates of C. albicans that are phenotypically similar to C. dubliniensis, whereas C. albicans 2 represents the sucrose-negative isolates formerly known as C. stellatoidea. One should note that these biotypes have been artificially created by the vendor for its databases and do not reflect actual taxonomic designations. For more information, the reader is referred to the work of Kwon-Chung et al. (12).


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

API 20C AUX system. High separation values were found with four carbohydrates in the API 20C AUX system (Table 1). Following 48 h (recommended for most yeast species) and 72 h of incubation, none of the 80 C. dubliniensis isolates tested were found to assimilate xylose (XYL) or MDG, whereas the database percentages for C. albicans 1 for these substrates are 88 and 85%, respectively. Positive assimilation of TRE was seen with 15% of the C. dubliniensis isolates after 48 h of incubation, but 99% were positive after 72 h of incubation. In contrast, the database indicates that 97% of C. albicans 1 can assimilate TRE after 48 h. Positive glycerol (GLY) assimilation was seen with 88% of the C. dubliniensis strains after 48 h of incubation, while all but two strains (98%) were positive after 72 h of incubation. However, the GLY assimilation results for C. albicans 1 in the database indicate that only 14% can assimilate this substrate. The numerical profiles constructed from C. dubliniensis reaction patterns after 48 and 72 h of incubation are shown in Table 2. Identification to the species level could be achieved after 48 h of incubation for 74% of the isolates, and an additional 11% were identified accurately to the genus level (low level of discrimination of C. dubliniensis and C. albicans 1). Misidentification of 11% of the C. dubliniensis isolates as C. albicans 1 was found, and 4% were unidentified. After 72 h of incubation, 95% of the 80 C. dubliniensis isolates were misidentified as C. albicans 1, 4% were unidentified, and 1% gave a correct identification of C. dubliniensis.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   API 20C AUX system tests useful for separation of C. dubliniensis from C. albicans


                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   Identification results for C. dubliniensis with API 20C AUX system (version 3.0 database)

ID 32 C system. High separation values were again found with four carbohydrates in the ID 32 C system (Table 3). After 48 h of incubation, none of the 80 isolates of C. dubliniensis tested with this system assimilated LAT, MDG, or XYL, whereas the database percentages for these substrates with C. albicans 1 are 96, 98, and 98%, respectively. Thirty percent of the C. dubliniensis strains assimilated TRE, whereas 97% of C. albicans 1 isolates assimilated TRE, as indicated in the database. Identification was correct to the species level for 70% of the 80 strains tested (Table 4). The remaining isolates (30%) were unidentified, giving a doubtful profile result. The only difference between these profiles and the ones that gave very good identification to the species level was an additional positive reaction for TRE assimilation. The current database percentage for TRE assimilation is 0% for C. dubliniensis.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 3.   ID 32 C system assimilation tests useful for separation of C. dubliniensis from C. albicans


                              
View this table:
[in this window]
[in a new window]
 
TABLE 4.   Identification results for C. dubliniensis with ID 32 C system (version 2.0 database)

RapID Yeast Plus system. The results obtained with the RapID Yeast Plus system showed that two tests had the potential to separate C. albicans and C. dubliniensis. After 4 h of incubation, results for alpha GLU and PHS with C. dubliniensis strains were 23 and 9%, respectively, whereas the database percentages for C. albicans are 94 and 76%, respectively. This product's database does not include data for C. dubliniensis, so correct identification was not possible. Thirty-two different profiles were associated with testing of the 80 C. dubliniensis isolates (Table 5). Test results indicated that 5% of the isolates had three profiles that gave a misidentification as C. zeylanoides and 4% of the isolates had one profile that gave a misidentification as C. stellatoidea. Eight profiles that gave no identification (not found in the code compendium) were seen for 10% of isolates tested, and the remaining isolates (81%) had 20 different profiles that gave a misidentification as C. albicans.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 5.   Identification results for C. dubliniensis with RapID Yeast Plus system (version 1.95 database)

VITEK YBC system. Results with the VITEK YBC system indicated that three test substrates (Table 6) had high separation values after 24 h of incubation. Results for MDG, XYL, and GLY assimilation were 10, 0, and 26%, respectively, for C. dubliniensis strains, whereas they are 95, 95, and 80%, respectively, for C. albicans. For 47 of 80 isolates tested, reincubation was required since C. dubliniensis (the database does not include data for this species) was recognized by the database as being the closest match to an underreactive strain of C. albicans. For the 47 isolates reincubated, the result for MDG assimilation was 64%, that for GLY assimilation was 51%, and that for XYL assimilation was 6%. This reincubation (to 48 h) resulted in increased positivity for tests that had the highest separation values when the results were more negative after 24 h of incubation. Thus, separation values for MDG and GLY assimilation decreased significantly, while XYL assimilation retained its high separation value. The bionumbers constructed from the C. dubliniensis reaction patterns after 24 and 48 h of incubation are shown in Table 7 along with the identification results. The majority of C. dubliniensis isolates (59%) were unidentified at 24 h. After 48 h of incubation, 99% were misidentified as C. albicans and 1% remained unidentified.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 6.   VITEK YBC tests useful for separation of C. dubliniensis from C. albicans


                              
View this table:
[in this window]
[in a new window]
 
TABLE 7.   Identification results for C. dubliniensis with VITEK YBC system (version 5.03 database)

VITEK 2 ID-YST system. Four substrates were found to have high separation values in the VITEK 2 ID-YST system (Table 8). After 15 h of incubation, the results for TRE, MDG, LAT, and PHS assimilation were 1, 1, 4, and 83%, respectively, whereas database percentages for C. albicans are 89, 99, 98, and 1%, respectively. Our tests showed percentages in line with those in the database except for PHS. The current database percentage of positivity for PHS for C. dubliniensis is 1%, but we found a higher level of positivity (83%). Correct identification to the species level was highest (98%) with the VITEK 2 ID-YST system compared to those for the other two products (API 20C AUX and ID 32 C) that include data for C. dubliniensis in their databases. The identification algorithm used for the VITEK 2 ID-YST system does not allow bionumber (numerical profile) construction since occasional questionable test results can arise from data in uncertainty zones near test thresholds. These questionable results were not included in the totals used to calculate percentages. Identification results are shown in Table 9. Identification was correct to the species level for 98% of the 80 isolates tested, with 1% of the isolates unidentified and 1% of the isolates misidentified.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 8.   VITEK 2 ID-YST tests useful for separation of C. dubliniensis from C. albicans


                              
View this table:
[in this window]
[in a new window]
 
TABLE 9.   Identification results for C. dubliniensis with VITEK 2 ID-YST system (version 1.01 database)

Wickerham and Burton procedure. Table 10 shows the results of conventional tests for assimilation of MDG, TRE, and XYL that were eventually positive for all 80 isolates of C. dubliniensis over the extended incubation period. Assimilation of MDG was slow for 16 isolates (20%) and was delayed for 7 isolates (9%), while TRE assimilation was slow for 10 isolates (12%). The most remarkable differences were seen with XYL assimilation, which was slow for 8 isolates (10%) and delayed for all but 9 isolates (11%), requiring 3 weeks of incubation for 63 isolates (79%) and 4 weeks of incubation for 6 isolates (8%). The remaining two isolates (2%) had very weak positive reactions even after the incubation period was prolonged to 31 days.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 10.   Conventional assimilations of C. dubliniensis by Wickerham and Burton method


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Comparative growth at 42 to 45°C for the differentiation of C. albicans and C. dubliniensis has been shown to yield equivocal results and should be used only to obtain presumptive evidence for the identification of C. dubliniensis. Most incubators are controlled within 4°C, and this may explain the differences in the results of studies cited above. Another potential source for these differences is variation in the components of the growth media.

Features such as abundant chlamydospore production, a dark green colony pigment on CHROMagar Candida medium, and the absence of intracellular beta GLU may be affected by phenotypic variation that can occur after subculture or long-term storage and are probably useful only for primary isolation (24). Since variability has been reported in the literature, the results obtained by these tests should be considered presumptive for C. dubliniensis and one or more confirmatory test methods should be used to obtain a definitive identification of this yeast.

Molecular methods are definitive but time-consuming and expensive and require special equipment not often available in many clinical laboratories. Our objective in this investigation was to determine if five commercially available yeast identification systems could be used to rapidly and accurately identify C. dubliniensis isolates recovered from clinical specimens.

C. dubliniensis is a recent addition to the API 20C AUX system database, and our results show that this system has the potential to be a means of identification of this yeast. Our data indicate that database modifications are suggested to avoid misidentification of C. dubliniensis as C. albicans 1 or no identification. The largest discrepancy that we observed was the positive TRE assimilation found for 15% of the C. dubliniensis isolates tested. It is reasonable to assume that incorporation of this variability in a future database would correctly identify all isolates that were misidentified or unidentified due to positive TRE reactions. According to the database, xylitol, N-acetyl-D-glucosamine, and sucrose should have had differential values, but our results after 48 h of incubation indicated similar percentages of assimilation (data not shown) for C. dubliniensis (98, 91, and 100%, respectively) and the expected reactions for C. albicans 1 (90, 99, and 97%, respectively).

Our data indicate that XYL assimilation was the most effective test in separating the two species. We also examined 100 isolates of C. albicans 1 with API 20C AUX kits (data not shown), and all but 4 (96%) were positive for XYL assimilation. Of the four isolates that were negative for XYL assimilation, three gave profiles characteristic of C. dubliniensis. Molecular analysis of these three strains with C. dubliniensis-specific PCR primers complementary to ACT1-associated intron sequences (6) showed that two of the isolates were actually C. dubliniensis (data not shown). This is consistent with the frequency (>2%) observed in a retrospective study (18) of a stock collection of C. albicans isolates. Our data that showed 98% positivity for XYL assimilation for the 98 C. albicans isolates suggest that more than 88% (the API 20C AUX kit database percentage) of C. albicans 1 strains can assimilate XYL. It would seem worthwhile for the manufacturer to use molecular methods to reexamine the XYL-negative isolates of C. albicans 1 whose data were included in the database. A higher percentage of XYL positivity for C. albicans 1 would provide more definitive separation of C. albicans from C. dubliniensis and allow the option of 72 h of incubation.

Data obtained with the ID 32 C system showed that TRE, MDG, and XYL assimilations were very useful in differentiating the two species. As noted with the API 20C AUX system, none of the C. dubliniensis isolates assimilated MDG or XYL, whereas 98% of the C. albicans 1 isolates whose data were included in the ID 32C database assimilated MDG and XYL. LAT assimilation (0% for C. dubliniensis and 96% for C. albicans) is another powerful substrate for the separation of these two species. Although 70% of isolates tested could be identified to the species level, the remaining isolates were unidentified due to a positive TRE reaction. We found that 30% of isolates assimilated TRE, in contrast to the expected 0% for C. dubliniensis in the database. It is clear that a modification to the TRE assimilation percentage for C. dubliniensis would result in a 100% correct identification to the species level. According to the database, palatinose assimilation should have had value in differentiating the two species, but our testing indicated similar percentages (data not shown) between C. dubliniensis (91%) and the expected percentage (100%) for C. albicans 1.

The RapID Yeast Plus system showed two tests (PHS and alpha GLU) with separation value, but a higher degree of variability was associated with them compared to useful tests from the other systems. Since 32 different profiles were observed for this 18-test system with 80 isolates of C. dubliniensis, it appears that the substrates used by the RapID Yeast Plus system are less useful for C. dubliniensis than tests present in the other two manual systems. It is difficult to predict the potential of database adjustments for inclusion of data for C. dubliniensis, but it seems likely that most strains of C. dubliniensis would not be identified to the species level. Of the most useful tests observed with the other commercial systems, only TRE assimilation and PHS tests are included in the RapID Yeast Plus system. Reactivity with TRE was nearly identical (data not shown) between C. dubliniensis (13%) and the expected percentage (14%) for C. albicans. While PHS showed some separation value, the difference between C. dubliniensis and C. albicans (9 and 76%, respectively) was not as remarkable as the differences seen with MDG and XYL assimilation present in all systems or LAT assimilation present in the ID 32 C and VITEK 2 ID-YST systems. While there is no single test in the RapID Yeast Plus system that clearly separates C. dubliniensis and C. albicans, a combination of test results, particularly negative PHS and alpha GLU results, may be useful for the identification of some strains of C. dubliniensis.

Assimilation of MDG, XYL, and GLY in the VITEK YBC system was found to be useful for the separation of C. dubliniensis from C. albicans after 24 h of incubation. As with the API 20C AUX and ID 32 C systems, the MDG and XYL substrates were significantly valuable, along with the GLY substrate in the API 20C AUX kit. Although differentiation with TRE was noted with the API 20C AUX and ID 32 C systems (Tables 1 and 3), it did not meet our criterion of a 50% difference with the VITEK YBC system. However, a lesser degree of separation (54% with C. dubliniensis compared to 90% with C. albicans; data not shown) was noted with this substrate, and TRE assimilation could have some utility if it were considered in combination with the other tests mentioned above. Since C. dubliniensis is not a taxon included in the VITEK YBC system database, a high percentage (59%) of the C. dubliniensis strains tested required reincubation. The YBC database recognized these isolates of C. dubliniensis as most closely resembling underreactive isolates of C. albicans. The normal occurrence of underreactive isolates of C. albicans that require reincubation is about 10% (unpublished data for isolates in the database). Since about 90% of C. albicans isolates are identified after 24 h of incubation and 0% of C. dubliniensis assimilate XYL after 24 h of incubation, it is likely that at least 90% of C. dubliniensis isolates would be accurately identified to the species level after 24 h of incubation if data for this new species were included in the VITEK YBC system database.

The most encouraging results were seen with the VITEK 2 ID-YST system, which was not yet commercially available at the time of our study. This product is being introduced and has the best potential of the systems included in the study for correct identification of C. dubliniensis to the species level. The database already includes this taxon, and although our data showed much higher reactivity for PHS, this had no impact on the final identifications. As with TRE assimilation in the API 20C AUX and ID 32 C systems, this difference in PHS reactivity seems attributable to the larger data set used in our study. Since numerical profiles are not generated with this system, it was not feasible to determine how uniform reaction patterns were for the 80 isolates tested.

The most consistent test results were found with the ID 32 C system. Even though this system incorporates 30 tests, only four different profile numbers were seen at 48 h with the 80 isolates of C. dubliniensis that were tested. It is possible that incubation for 24 h would have resulted in more profile variation, as was the case when we compared data from the API 20C AUX kit after 48 and 72 h of incubation. Even considering this difference related to incubation time, the profile number variability was much less than that observed with the RapID Yeast Plus or the VITEK YBC system.

As mentioned above, our results indicate that database modifications are suggested for TRE assimilation with the API 20C AUX and ID 32 C systems to allow correct identification of 15 and 30%, respectively, of the C. dubliniensis isolates that gave either misidentification or no identification results. Our data indicate that the RapID Yeast Plus system may not have the optimal substrates present for differentiation of C. dubliniensis, but it has potential to identify C. dubliniensis to the genus level (but requires additional confirmatory testing for definitive separation from C. albicans). It appears that incorporation of our data into the VITEK YBC system database could allow accurate recognition of C. dubliniensis. It is clear that current users of these four products should be aware of the bionumbers (profile numbers) shown in Tables 2, 4, 5, and 7 so that this important species can be recognized rapidly in today's clinical laboratory setting.


    ACKNOWLEDGMENT

Work performed in the laboratory of D. C. Coleman was supported by Irish Health Research Board grants 41/96 and 05/97.


    FOOTNOTES

* Corresponding author. Mailing address: Dept. 015-B1/L3, bioMérieux, Inc., 595 Anglum Rd., Hazelwood, MO 63042-2320. Phone: (314) 731-7456. Fax: (314) 731-7454. E-mail: dave_pincus{at}na.biomerieux.com.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Barnett, J. A., R. W. Payne, and D. Yarrow. 1990. Yeasts: characteristics and identification, 2nd ed. Cambridge University Press, Cambridge, United Kingdom
2. Bikandi, J., R. San Millán, M. D. Moragues, G. Cebas, M. Clarke, D. C. Coleman, D. J. Sullivan, G. Quindós, and J. Pontón. 1998. Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes. J. Clin. Microbiol. 36:2428-2433[Abstract/Free Full Text].
3. Boerlin, P., F. Boerlin-Petzold, C. Durussel, M. Addo, J.-L. Pagani, J.-P. Chave, and J. Bille. 1995. Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users. J. Clin. Microbiol. 33:1129-1135[Abstract].
4. Coleman, D., D. Sullivan, B. Harrington, K. Haynes, M. Henman, D. Shanley, D. Bennett, G. Moran, C. McCreary, and L. O'Neill. 1997. Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients. Oral Dis. 3(Suppl. 1):S96-S101.
5. Coleman, D. C., D. J. Sullivan, D. E. Bennett, G. P. Moran, H. J. Barry, and D. B. Shanley. 1997. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 11:557-567[Medline].
6. Donnelly, S. M., D. J. Sullivan, D. B. Shanley, and D. C. Coleman. 1999. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 145:1871-1882[Abstract/Free Full Text].
7. Gilfillan, G. D., D. J. Sullivan, K. Haynes, T. Parkinson, D. C. Coleman, and N. A. R. Gow. 1998. Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 144:829-838[Abstract/Free Full Text].
8. Jabra-Rizk, M. A., A. A. M. A. Baqui, J. I. Kelley, W. A. Falkler, Jr., W. G. Merz, and T. F. Meiller. 1999. Identification of Candida dubliniensis in a prospective study of patients in the United States. J. Clin. Microbiol. 37:321-326[Abstract/Free Full Text].
9. Joly, S., C. Pujol, M. Rysz, K. Vargas, and D. R. Soll. 1999. Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis. J. Clin. Microbiol. 37:1035-1044[Abstract/Free Full Text].
10. Kirkpatrick, W. R., S. G. Revankar, R. K. McAtee, J. L. Lopez-Ribot, A. W. Fothergill, D. I. McCarthy, S. E. Sanche, R. A. Cantu, M. G. Rinaldi, and T. F. Patterson. 1998. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J. Clin. Microbiol. 36:3007-3012[Abstract/Free Full Text].
11. Kreger-van Rij, N. J. W. (ed.). 1984. The yeasts a taxonomic study, 3rd ed. Elsevier Science Publishers B. V., Amsterdam, The Netherlands
12. Kwon-Chung, K. J., W. S. Riggsby, R. A. Uphoff, J. B. Hicks, W. L. Whelan, E. Reiss, B. B. Magee, and B. L. Wickes. 1989. Genetic differences between type I and type II Candida stellatoidea. Infect. Immun. 57:527-532[Abstract/Free Full Text].
13. McCullough, M., B. Ross, and P. Reade. 1995. Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus. J. Clin. Microbiol. 33:696-700[Abstract].
14. McCullough, M. J., K. V. Clemons, and D. A. Stevens. 1999. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J. Clin. Microbiol. 37:417-421[Abstract/Free Full Text].
15. Meis, J. F., M. Ruhnke, B. E. De Pauw, F. C. Odds, W. Siegert, and P. E. Verweij. 1999. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg. Infect. Dis. 5:150-153[Medline].
16. Moran, G. P., D. J. Sullivan, M. C. Henman, C. E. McCreary, B. J. Harrington, D. B. Shanley, and D. C. Coleman. 1997. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41:617-623[Abstract].
17. Moran, G. P., D. Sanglard, S. M. Donnelly, D. B. Shanley, D. J. Sullivan, and D. C. Coleman. 1998. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 42:1819-1830[Abstract/Free Full Text].
18. Odds, F. C., L. Van Nuffel, and G. Dams. 1998. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J. Clin. Microbiol. 36:2869-2873[Abstract/Free Full Text].
19. Pfaller, M. A., S. A. Messer, S. Gee, S. Joly, C. Pujol, D. J. Sullivan, D. C. Coleman, and D. R. Soll. 1999. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J. Clin. Microbiol. 37:870-872[Abstract/Free Full Text].
20. Pinjon, E., D. Sullivan, I. Salkin, D. Shanley, and D. Coleman. 1998. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J. Clin. Microbiol. 36:2093-2095[Abstract/Free Full Text].
21. Salkin, I. F., W. R. Pruitt, A. A. Padhye, D. Sullivan, D. Coleman, and D. H. Pincus. 1998. Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States. J. Clin. Microbiol. 36:1467[Free Full Text]. (Letter.)
22. Schoofs, A., F. C. Odds, R. Colebunders, M. Ieven, and H. Goossens. 1997. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 16:296-300[Medline].
23. Sullivan, D., and D. Coleman. 1997. Candida dubliniensis: an emerging opportunistic pathogen. Curr. Top. Med. Mycol. 8:15-25[Medline].
24. Sullivan, D., and D. Coleman. 1998. Candida dubliniensis: characteristics and identification. J. Clin. Microbiol. 36:329-334[Free Full Text].
25. Sullivan, D., K. Haynes, J. Bille, P. Boerlin, L. Rodero, S. Lloyd, M. Henman, and D. Coleman. 1997. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 35:960-964[Abstract].
26. Sullivan, D. J., M. C. Henman, G. P. Moran, L. C. O'Neill, D. E. Bennett, D. B. Shanley, and D. C. Coleman. 1996. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J. Med. Microbiol. 44:399-408[Abstract/Free Full Text].
27. Sullivan, D. J., T. J. Westerneng, K. A. Haynes, D. E. Bennett, and D. C. Coleman. 1995. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141:1507-1521[Abstract/Free Full Text].
28. Warren, N. G., and K. C. Hazen. 1999. Candida, Cryptococcus, and other yeasts of medical importance, p. 1184-1199. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C
29. Wickerham, L. J., and K. A. Burton. 1948. Carbon assimilation tests for the classification of yeasts. J. Bacteriol. 56:363-371[Free Full Text].


Journal of Clinical Microbiology, November 1999, p. 3533-3539, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • McManus, B. A., Coleman, D. C., Moran, G., Pinjon, E., Diogo, D., Bougnoux, M.-E., Borecka-Melkusova, S., Bujdakova, H., Murphy, P., d'Enfert, C., Sullivan, D. J. (2008). Multilocus Sequence Typing Reveals that the Population Structure of Candida dubliniensis Is Significantly Less Divergent than That of Candida albicans. J. Clin. Microbiol. 46: 652-664 [Abstract] [Full Text]  
  • Hata, D. J., Hall, L., Fothergill, A. W., Larone, D. H., Wengenack, N. L. (2007). Multicenter Evaluation of the New VITEK 2 Advanced Colorimetric Yeast Identification Card. J. Clin. Microbiol. 45: 1087-1092 [Abstract] [Full Text]  
  • Romeo, O., Racco, C., Criseo, G. (2006). Amplification of the Hyphal Wall Protein 1 Gene To Distinguish Candida albicans from Candida dubliniensis.. J. Clin. Microbiol. 44: 2590-2592 [Abstract] [Full Text]  
  • Sahand, I. H., Moragues, M. D., Eraso, E., Villar-Vidal, M., Quindos, G., Ponton, J. (2005). Supplementation of CHROMagar Candida Medium with Pal's Medium for Rapid Identification of Candida dubliniensis. J. Clin. Microbiol. 43: 5768-5770 [Abstract] [Full Text]  
  • Al Mosaid, A., Sullivan, D. J., Polacheck, I., Shaheen, F. A., Soliman, O., Al Hedaithy, S., Al Thawad, S., Kabadaya, M., Coleman, D. C. (2005). Novel 5-Flucytosine-Resistant Clade of Candida dubliniensis from Saudi Arabia and Egypt Identified by Cd25 Fingerprinting. J. Clin. Microbiol. 43: 4026-4036 [Abstract] [Full Text]  
  • Carr, M. J., Clarke, S., O'Connell, F., Sullivan, D. J., Coleman, D. C., O'Connell, B. (2005). First Reported Case of Endocarditis Caused by Candida dubliniensis. J. Clin. Microbiol. 43: 3023-3026 [Abstract] [Full Text]  
  • Davis, L. E., Shields, C. E., Merz, W. G. (2005). Use of a Commercial Reagent Leads to Reduced Germ Tube Production by Candida dubliniensis. J. Clin. Microbiol. 43: 2465-2466 [Abstract] [Full Text]  
  • Pancholi, P., Park, S., Perlin, D., Kubin, C., Della-Latta, P. (2004). Molecular Characterization of Fluconazole Resistance in a Case of Candida albicans Ocular Infection. J. Clin. Microbiol. 42: 5938-5939 [Abstract] [Full Text]  
  • Marot-Leblond, A., Grimaud, L., David, S., Sullivan, D. J., Coleman, D. C., Ponton, J., Robert, R. (2004). Evaluation of a Rapid Immunochromatographic Assay for Identification of Candida albicans and Candida dubliniensis. J. Clin. Microbiol. 42: 4956-4960 [Abstract] [Full Text]  
  • Massonet, C., Van Eldere, J., Vaneechoutte, M., De Baere, T., Verhaegen, J., Lagrou, K. (2004). Comparison of VITEK 2 with ITS2-Fragment Length Polymorphism Analysis for Identification of Yeast Species. J. Clin. Microbiol. 42: 2209-2211 [Abstract] [Full Text]  
  • Al Mosaid, A., Sullivan, D. J., Coleman, D. C. (2003). Differentiation of Candida dubliniensis from Candida albicans on Pal's Agar. J. Clin. Microbiol. 41: 4787-4789 [Abstract] [Full Text]  
  • Fotedar, R., Al Hedaithy, S. S. A. (2003). Candida dubliniensis at a University Hospital in Saudi Arabia. J. Clin. Microbiol. 41: 1907-1911 [Abstract] [Full Text]  
  • Mosca, C. O., Moragues, M. D., Llovo, J., Al Mosaid, A., Coleman, D. C., Ponton, J. (2003). Casein Agar: a Useful Medium for Differentiating Candida dubliniensis from Candida albicans. J. Clin. Microbiol. 41: 1259-1262 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L., Hollis, R. J., Jones, R. N. (2003). In Vitro Activities of Voriconazole, Posaconazole, and Four Licensed Systemic Antifungal Agents against Candida Species Infrequently Isolated from Blood. J. Clin. Microbiol. 41: 78-83 [Abstract] [Full Text]  
  • Yang, C. W., Barkham, T. M. S., Chan, F. Y., Wang, Y. (2003). Prevalence of Candida Species, Including Candida dubliniensis, in Singapore. J. Clin. Microbiol. 41: 472-474 [Abstract] [Full Text]  
  • Sancak, B., Rex, J. H., Paetznick, V., Chen, E., Rodriguez, J. (2003). Evaluation of a Method for Identification of Candida dubliniensis Bloodstream Isolates. J. Clin. Microbiol. 41: 489-491 [Abstract] [Full Text]  
  • Selvarangan, R., Limaye, A. P., Cookson, B. T. (2002). Rapid Identification and Differentiation of Candida albicans and Candida dubliniensis by Capillary-Based Amplification and Fluorescent Probe Hybridization. J. Clin. Microbiol. 40: 4308-4312 [Abstract] [Full Text]  
  • Gee, S. F., Joly, S., Soll, D. R., Meis, J. F. G. M., Verweij, P. E., Polacheck, I., Sullivan, D. J., Coleman, D. C. (2002). Identification of Four Distinct Genotypes of Candida dubliniensis and Detection of Microevolution In Vitro and In Vivo. J. Clin. Microbiol. 40: 556-574 [Abstract] [Full Text]  
  • Al Mosaid, A., Sullivan, D., Salkin, I. F., Shanley, D., Coleman, D. C. (2001). Differentiation of Candida dubliniensis from Candida albicans on Staib Agar and Caffeic Acid-Ferric Citrate Agar. J. Clin. Microbiol. 39: 323-327 [Abstract] [Full Text]  
  • Slifkin, M. (2000). Tween 80 Opacity Test Responses of Various Candida Species. J. Clin. Microbiol. 38: 4626-4628 [Abstract] [Full Text]  
  • Peltroche-Llacsahuanga, H., Schmidt, S., Seibold, M., Lütticken, R., Haase, G. (2000). Differentiation between Candida dubliniensis and Candida albicans by Fatty Acid Methyl Ester Analysis Using Gas-Liquid Chromatography. J. Clin. Microbiol. 38: 3696-3704 [Abstract] [Full Text]  
  • Park, S., Wong, M., Marras, S. A. E., Cross, E. W., Kiehn, T. E., Chaturvedi, V., Tyagi, S., Perlin, D. S. (2000). Rapid Identification of Candida dubliniensis Using a Species-Specific Molecular Beacon. J. Clin. Microbiol. 38: 2829-2836 [Abstract] [Full Text]  
  • Meis, J. F. G. M., Verduyn Lunel, F. M., Verweij, P. E., Voss;, A., Coleman, D. (2000). One-Year Prevalence of Candida dublinienis in a Dutch University Hospital. J. Clin. Microbiol. 38: 3139-3140 [Full Text]  
  • Jabra-Rizk, M. A., Falkler, W. A. Jr., Merz, W. G., Baqui, A. A. M. A., Kelley, J. I., Meiller, T. F. (2000). Retrospective Identification and Characterization of Candida dubliniensis Isolates among Candida albicans Clinical Laboratory Isolates from Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Individuals. J. Clin. Microbiol. 38: 2423-2426 [Abstract] [Full Text]  
  • Polacheck, I., Strahilevitz, J., Sullivan, D., Donnelly, S., Salkin, I. F., Coleman, D. C. (2000). Recovery of Candida dubliniensis from Non-Human Immunodeficiency Virus-Infected Patients in Israel. J. Clin. Microbiol. 38: 170-174 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pincus, D. H.
Right arrow Articles by Hearn, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pincus, D. H.
Right arrow Articles by Hearn, V.